HN2008000621A - Metodo para la anticopcepcion hormonal preventiva bajo demanda - Google Patents

Metodo para la anticopcepcion hormonal preventiva bajo demanda

Info

Publication number
HN2008000621A
HN2008000621A HN2008000621A HN2008000621A HN2008000621A HN 2008000621 A HN2008000621 A HN 2008000621A HN 2008000621 A HN2008000621 A HN 2008000621A HN 2008000621 A HN2008000621 A HN 2008000621A HN 2008000621 A HN2008000621 A HN 2008000621A
Authority
HN
Honduras
Prior art keywords
anticopception
hormonal
preventive
under demand
present
Prior art date
Application number
HN2008000621A
Other languages
English (en)
Inventor
Schmidt-Gollwitzer Karim
Stock Gunter
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of HN2008000621A publication Critical patent/HN2008000621A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE RELACION A CON UN METODO DE ANTICOPCEPCION HORMONAL QUE COMPRENDE ADMINISTRAR UNA PREPARACION FARMACEUTCA QUE COMPRENDE AL MENOS UN PROGESTOGENO POR VIA TRANSDERMICA, BAJO DEMANDA Y EN UNA SOLA OCASION, EN ANTICIPACION DEL ENCUENTRO SEXUAL. NOTA: LA PRESENTE INVENCION REIVINDICA LOS COMPUESTOS DE PROGESTOGENOS SELECCIONADOS DE LOS SIGUIENTES: DESOGESTREL, ETONORGESTREL, GESTODENO, LEVONORGESTREL, TRIMEGESTONA. TAMBIEN REIVINDICA UN ESTROGENO COMO EL ETINILESTRADIOL
HN2008000621A 2005-10-19 2008-04-21 Metodo para la anticopcepcion hormonal preventiva bajo demanda HN2008000621A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005050729A DE102005050729A1 (de) 2005-10-19 2005-10-19 Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption

Publications (1)

Publication Number Publication Date
HN2008000621A true HN2008000621A (es) 2011-07-22

Family

ID=37762565

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2008000621A HN2008000621A (es) 2005-10-19 2008-04-21 Metodo para la anticopcepcion hormonal preventiva bajo demanda

Country Status (13)

Country Link
US (3) US20080311180A1 (es)
EP (1) EP1937275A1 (es)
JP (2) JP2009512658A (es)
KR (1) KR20080056774A (es)
CN (1) CN101340915A (es)
BR (1) BRPI0617683A2 (es)
CA (1) CA2626567C (es)
CR (1) CR9908A (es)
DE (1) DE102005050729A1 (es)
EC (1) ECSP088390A (es)
GT (1) GT200800038A (es)
HN (1) HN2008000621A (es)
WO (1) WO2007045513A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0819571A2 (pt) * 2007-12-20 2019-09-24 Teva Womenss Health Inc "método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica"
US20120129825A1 (en) * 2009-04-14 2012-05-24 Andre Ulmann Method for on-demand contraception using levonorgestrel or norgestrel
AU2010237120B8 (en) 2009-04-14 2015-11-26 Laboratoire Hra-Pharma Method for on-demand contraception
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
BR112015011212A2 (pt) 2012-11-22 2017-07-11 Bayer Pharma AG uso e regime de aplicação de uma composição farmacêutica contendo levonorgestrel e um inibidor de cox para a contracepção necessária ("on demand")
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
BR112015029214A2 (pt) 2013-05-23 2017-07-25 Bayer Pharma AG composição farmacêutica, seu uso e regime de aplicação dessa composição farmacêutica para contracepção conforme a necessidade
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
DE4229820C2 (de) * 1992-09-07 1998-12-03 Jenapharm Gmbh Pharmazeutische Zubereitung auf Gestagen-Basis
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
PT787002E (pt) * 1994-10-24 2007-03-30 Schering Ag Antagonistas de progesterona competitivos para controlo de fertilidade feminina orientado pela necessidade
AU781835B2 (en) * 1999-08-31 2005-06-16 Schering Aktiengesellschaft Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
WO2003093322A2 (en) * 2002-04-30 2003-11-13 The Population Council, Inc. Carrageenan based antimicrobial compositions
UA89766C2 (en) * 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
EA011160B1 (ru) * 2003-12-12 2009-02-27 Шеринг Акциенгезельшафт Композиция для трансдермальной доставки гормонов без необходимости использования агентов, усиливающих проникновение, и ее применения

Also Published As

Publication number Publication date
US20070111976A1 (en) 2007-05-17
KR20080056774A (ko) 2008-06-23
CR9908A (es) 2008-05-21
CA2626567A1 (en) 2007-04-26
CN101340915A (zh) 2009-01-07
BRPI0617683A2 (pt) 2011-08-02
EP1937275A1 (de) 2008-07-02
ECSP088390A (es) 2008-05-30
GT200800038A (es) 2009-04-01
US20080311180A1 (en) 2008-12-18
DE102005050729A1 (de) 2007-04-26
JP2009512658A (ja) 2009-03-26
US20130089574A1 (en) 2013-04-11
WO2007045513A1 (de) 2007-04-26
CA2626567C (en) 2013-12-03
JP2014001239A (ja) 2014-01-09

Similar Documents

Publication Publication Date Title
HN2008000621A (es) Metodo para la anticopcepcion hormonal preventiva bajo demanda
PE20060275A1 (es) Composicion farmaceutica que contiene progestina y estrogeno para el tratamiento de trastorno disforico premenstrual
AR057060A1 (es) Composiciones de tanaproget que contienen etinil estradiol
PE20070327A1 (es) Composicion que comprende una progestina y un estrogeno
CL2011003172A1 (es) Composicion farmaceutica que comprende a) un excepiente, b) al menos un precursor de esteroides sexuales, c) al menos un modulador selectivo del receptor de estrogenos o una antiestrogeno y no contiene una progestina y/o un estrogeno; kit farmaceutico; y uso para reducir o eliminar sofocos, sintomas vasomotores y sudores nocturnos.
PE20211588A1 (es) Compuestos y sus usos para aliviar sintomas asociados a la menopausia
PE20120860A1 (es) Combinacion farmaceutica que comprende levonorgestrel en combinacion con piroxicam, indometacina o diclofenaco
CR7611A (es) Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona
AR082998A1 (es) Asociacion farmaceutica para tratar y/o prevenir mioma y/o endometriosis, uso de resveratrol y progestogeno, composicion farmaceutica para tratamiento y/o prevencion de mioma y/o endometriosis, medicamento para tratamiento y/o prevencion de mioma y/o endometriosis, kit y metodo para tratamiento y/o prevencion de mioma y/o endometriosis
PE20061415A1 (es) Composicion farmaceutica que contiene gestagenos y/o estrogenos y 5-metil-(6s)-tetrahidrofolato
ECSP088123A (es) Anticoncepcion oral con trimegestona
AR032204A1 (es) Complejos de inclusion de ciclodextrina-drospirenona
ECSP088796A (es) Metodos para la prevencion y tratamiento de condiciones que surgen de deficiencia de estrogeno local
CR7022A (es) Productos esteroides hormonales y metodos para su preparacion
PA8805001A1 (es) Sistema de administracion vaginal
ECSP056095A (es) Métodos y composiciones farmacéuticas para la obtención confiable de niveles aceptables de testosterona en suero
NI201000183A (es) Regímenes de dosificación de antiprogestina.
ECSP055574A (es) Uso de derivados de tio-oxindol en el tratamiento de condiciones relacionadas con hormonas.
PE20211239A1 (es) Compuestos y sus usos para aliviar sintomas asociados a la menopausia
RS53876B1 (en) PARENTERAL PHARMACEUTICAL FORM, WHICH RELEASES AROMATASE AND GESTAGEN BLOCKERS, FOR THE TREATMENT OF ENDOMETRIOSIS
CO6630107A2 (es) Formas de dosificación sólidas orales con dosis muy bajas para hrt
IN2012DN04867A (es)
PE20040157A1 (es) Progestinas no esteroides
AR121864A1 (es) Composiciones anticonceptivas con efectos adversos reducidos
GT200900296A (es) Composición farmacéutica que comprende la combinación de un agente anti inflamatorio no esteroideo y un agente anticonvulsivante.